Views & Analysis Steps to building a more patient-centric industry Lack of access, strict regulations, and demanding schedules have made it extremely difficult for patients to participate in clinical trials.
News Novo Nordisk's dropping share price spells the end for CEO Novo Nordisk's chief executive Lars Fruergaard Jørgensen is stepping down by "mutual agreement" with the company's board.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.